Home/Filings/4/0001372514-23-000037
4//SEC Filing

Parsons Erin 4

Accession 0001372514-23-000037

CIK 0001372514other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 8:15 PM ET

Size

5.4 KB

Accession

0001372514-23-000037

Insider Transaction Report

Form 4
Period: 2023-03-03
Parsons Erin
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-03+8,0008,000 total
    Exercise: $3.83Exp: 2033-03-03Common Stock (8,000 underlying)
Footnotes (1)
  • [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024.

Issuer

KIORA PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1
  • filerCIK 0001895795

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:15 PM ET
Size
5.4 KB